Reassessing the evidence of a survival advantage in Type 2 diabetes treated with metformin compared with controls without diabetes: a retrospective cohort study.
Matthew Thomas KeysMikael ThinggaardLisbeth Aagaard LarsenDorthe Almind PedersenNina Sahlertz KristiansenKaare ChristensenPublished in: International journal of epidemiology (2022)
Treatment initiation by metformin monotherapy in Type 2 diabetes was not associated with survival equal or superior to that of the general population without diabetes. Our contrasting findings compared with previous research are unlikely to be the result of differences in epidemiological or methodological parameters.